Skip to main content
Premium Trial:

Request an Annual Quote

B-Bridge Raises $4.2M in Private Funding

NEW YORK, March 29 (GenomeWeb News) - B-Bridge International has raised $4.2 million in funding, mostly from Japanese institutional investors, the company said today.

 

B-Bridge, which is based in Sunnyvale, Calif., and provides tools and technology for life science research, said it will use the funding to expand its research and development capabilities, and to develop a "network infrastructure" to provide researchers with information about its tools and services.

 

The majority of the funding came from Bio-sight Capital of Osaka, Hokkaido Venture Capital of Sapporo, and the Marubeni Corporation of Tokyo, as well as from current shareholders.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.